Clinical and economic effects of central venous catheters on oncology patient care

Journal of Chemotherapy

Volumn 19, Issue 3, 2007, Pages 309-314

  Console, Giangiuseppe ^a   Calabro C ^a   Nardulli, P ^a   Digiuseppe, F ^a   Rucci, A ^a   Russo, P ^b   Geppetti, P ^b  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Activated partial thromboplastin time (aPTT); Catheter Related Bloodstream Infections (CRBSI); Central Venous Catheters (CVC); Polyurethane (PU); Prothrombin time (PT); Standard Deviation (DS); Total Parenteral Nutrition (TPN)

Indexed keywords

ANTIBIOTIC AGENT; POLYURETHAN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLOOD ANALYSIS; CANCER PATIENT; CATHETER COMPLICATION; CATHETER INFECTION; CATHETERIZATION; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ECONOMIC ASPECT; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; MALE; PATIENT CARE; PATIENT MONITORING;

EID: 34447498393     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2007.19.3.309     Document Type: Article

References (21)

1. Lokich JJ, Becker B. Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy. Cancer 1983; 52:1586-9.
2. Bern MM, Lokich JJ, Wallach SR, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med 1990; 112:423-8.
3. Raad I, Safar H. Long term central venosus catheters. In: Catheter - related infections. Edited by Seifert H, Farr, B, New York: Marcel Dekker Inc.; 1997: 307-324.
4. Haire WD, Lieberman RP, Edney J, et al. Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation. Cancer 1990; 66:900-8.
5. Anderson AJ, Krasnow SH, Boyer MW, et al. Thrombosis: the major Hickman catheter complication in patient with solid tumor. Chest 1989; 95:71-5.
6. Herrmann M, Vaudaux PE, Pittet D, et al. Fibronectin, fibrinogen and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis 1988; 158: 693-701.
7. CDC Guidelines for the prevention of intravascular catheter-related infections: Atlanta; 2002.
8. Aster RH. Heparin-induced thrombocytopenia and thrombosis. N Engl J Med 1995; 332: 1374.
9. Warkentin TE, Kelton JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001; 344: 1286.
10. Sheng WH, Ko WJ, Wang JT, Chang SC, Hsueh PR, Luh KT. Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients. Diagn Microbiol Infect Dis 2000; 38(1):1-5.
11. Campisi C, Assenza M, Zappala A, et al. Surgical technique and biomaterials for totally implanted port catheter system. J Chemother 1997; 9:155-156.
12. Agee KR, Balk RA. Central venous catheterisation in the critically ill patient. Crit Care Clin 1992; 8: 677-686.
13. Hinke DH, Zandt-Stastny DA, Goodman LR, Quebbeman EJ, Krzywda EA, Andris DA. Pinch-off syndrome: a complication of implantable subclavian venous access devices. Radiology 1990; 177: 353-356.
14. CDC. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 - June 2001. Am J Infect Control 2001; 6: 404-21.
15. Dobbins BM, Carton JA, Kite P, McMahon MJ, Wilcox MH. Each lumen is a potential source of central venous catheter-related bloodstream infection. Crit Care Med 2003; 31 (6): 1688-90.
16. CDC. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999. Am J Infect Control 1999; 27:520-32.
17. Giuliani F, Longo M, Colucci G. A Retrospective analysis of 340 central venous access catheters for chemotherapy in patients with cancer. Ann Oncol 2005; 16(Suppl.4): 168.
18. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1994; 271:1598-1601.
19. CDC. Guidelines for the Prevention of Intravascular Catheter-Related Infections: Atlanta; 2002.
20. Schierholz JM, Beuth J, Rump A, Konig DP, Pulverer G. Novel strategies to prevent catheter-associated infections in oncology patients. J Chemother 2001: 13, Spec Issue n. 1:239-50.
21. Trueman P, Drummond M, Hutton J. Developing guidance for budget impact analysis. Pharmacoeconomics 2001; 19:609-621.